Sara N Musetti

Affiliations: 
2021 Eshelman School of Pharmacy University of North Carolina, Chapel Hill, Chapel Hill, NC 
Google:
"Sara Musetti"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Musetti SN, Huang L. (2021) Tinagl1 Gene Therapy Suppresses Growth and Remodels the Microenvironment of Triple Negative Breast Cancer. Molecular Pharmaceutics. 18: 2032-2038
Zhu H, Liu Q, Miao L, et al. (2020) Remodeling the fibrotic tumor microenvironment of desmoplastic melanoma to facilitate vaccine immunotherapy. Nanoscale
Musetti S, Leaf H. (2020) Tinagl1 gene therapy for tumor-wide remodeling of triple negative breast cancer European Journal of Cancer. 138: S37-S38
Xiong Y, Song W, Shen L, et al. (2020) Oral Metformin and Polymetformin Reprogram Immunosuppressive Microenvironment and Boost Immune Checkpoint Inhibitor Therapy in Colorectal Cancer Advanced Therapeutics. 3: 2000168
Qi C, Musetti S, Fu LH, et al. (2019) Biomolecule-assisted green synthesis of nanostructured calcium phosphates and their biomedical applications. Chemical Society Reviews
Das M, Musetti S, Huang L. (2018) RNA Interference-Based Cancer Drugs: The Roadblocks, and the "Delivery" of the Promise. Nucleic Acid Therapeutics
Musetti S, Huang L. (2018) Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy. Acs Nano
Liu L, Wang Y, Miao L, et al. (2017) Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer. Molecular Therapy : the Journal of the American Society of Gene Therapy
Liu Q, Zhu H, Liu Y, et al. (2017) BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma. Cancer Immunology, Immunotherapy : Cii
Song W, Musetti SN, Huang L. (2017) Nanomaterials for cancer immunotherapy. Biomaterials. 148: 16-30
See more...